E-mail a Wiley Online Library Link

Elizabeth Csaszar, Sandra Cohen and Peter W. Zandstra Blood stem cell products: Toward sustainable benchmarks for clinical translation BioEssays 35

Article first published online: 21 NOV 2012 | DOI: 10.1002/bies.201200118

Thumbnail image of graphical abstract

The robust and reliable translation of ex vivo expanded umbilical cord blood derived hematopoietic stem and progenitor cells for the wide-spread clinical use for transplantation will require the implementation of bioengineering strategies to overcome technical and economic challenges of scale-up, reproducibility, and product quality assurance.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field